InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Paggiarino Dario A., Directeur Médical. Director active across 1 companies, notably EyePoint Pharmaceuticals, Inc.. Cumulatively, 5 reports have been logged. The latest transaction was filed on 28 February 2022 — Levée d'options. Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
04,105 shares0
Common Stock
SEC:0001562180-22-002136:0·
04,966 shares0
Common Stock
SEC:0001562180-22-001413·
04,966 shares0
Common Stock
SEC:0001562180-22-001413:0·
01,420 shares0
Common Stock
SEC:0001562180-21-004274·
01,420 shares0
Common Stock
SEC:0001562180-21-004274:0·
5 of 5 declarations
About Paggiarino Dario A.
Paggiarino Dario A. is the Chief Medical Officer of EyePoint Pharmaceuticals, Inc. He is responsible for leading the company's medical and clinical initiatives. His role is essential for the development of new treatments and ensuring compliance with medical regulations. Dario brings significant expertise in the medical field, contributing to the mission of EyePoint Pharmaceuticals.
